Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.
about
Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coliCyanobacterial lipopolysaccharides and human health - a reviewEnterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and preventionModulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans ModelComparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/INovel antigens for enterotoxigenic Escherichia coli vaccinesVaccines against enterotoxigenic Escherichia coli.Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross talk mechanisms modulate extracellular proteolytic activitiesPrevention and self-treatment of traveler's diarrhea.Phytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice.Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella antigens.A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phasMucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coliProtective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model.Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.Structure, Function and Regulation of Outer Membrane Proteins Involved in Drug Transport in Enterobactericeae: the OmpF/C - TolC CaseA sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccinesEvolutionary and functional relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli.Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B.Recombinant outer membrane protein C of Aeromonas hydrophila elicits mixed immune response and generates agglutinating antibodies.MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA.A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407.Surface display of the HPV L1 capsid protein by the autotransporter Shigella IcsA.Enterotoxigenic Escherichia coli (ETEC) adhesin-toxoid MEFA (multiepitope fusion antigen) CFA/I/II/IV-3xSTaN12S-mnLTG192G/L211A derived antibodies inhibit adherence of seven adhesins (CFA/I, CFA/II & CFA/IV), neutralize enterotoxicity of both toxinsIntestinal Pathogenic Escherichia coli: Insights for Vaccine Development.Characterization of immune response elicited by the recombinant outer membrane protein OmpF of Aeromonas hydrophila, a potential vaccine candidate in murine model.
P2860
Q21135001-7D283675-8054-4FA6-8191-249811A60B40Q21245821-2CC067BD-92A2-4ED7-A071-F077B1B7A5C9Q24530558-A7349E62-E08D-4E3E-BDE7-1BD231968A5BQ30385057-32EA2525-3EE7-43AD-B5BC-EE25AB346833Q34334202-0BBBFE6A-6361-4ABD-A476-D51A5CBC711EQ34334284-516194D9-C0B1-4432-9754-F8745275A066Q34349166-BDF98143-35BF-4D28-894C-341BBCD716E7Q34594874-BE7118EC-348A-4349-85A7-38CE7EDBCEB8Q34696713-E6BB59A5-275A-41FD-996E-19C1435C2451Q34974972-DF1E3C36-0B3D-4B34-AFB9-CA650EBF3B91Q35125351-ED7F162C-16F0-4FC1-9705-F556A52A8DD5Q35164830-2D3EADE1-D2D2-4148-998B-8C30CF90221AQ35213355-E50C01E1-5874-4810-A881-0AC833E99F8CQ35549950-D537AD8E-16CC-4EFE-9329-D7FCA1796013Q35598235-854B80B7-CE19-47A8-AE18-CEE38150839DQ35784019-01971CFC-D233-4636-A15D-9CE4AB8647DCQ35920317-46EE9ED5-AAC8-4DDC-968D-DEDE200FCD0DQ35998767-E7B85034-C79A-4A39-AF70-54C68BC8FE69Q36172686-69E3FA5D-B5AE-41DC-BD8F-E3A0AB53265BQ36743082-347A16FF-42F3-401D-81C3-45BEAA95689FQ36950003-938ADB31-781C-4BEC-B939-00DCB42D7CF5Q37623734-6653434E-C849-43E9-9492-FB92BB226459Q38032878-9DE6C15C-504E-4DE1-97BB-63905E8A5953Q39656225-F95220E7-6C10-45CD-B8B5-8FDE84E6416DQ39657777-120F49BC-FF9E-4D10-840B-E6A6345F95E0Q39666526-B0A1FD7F-66EF-4DA9-8DA1-C5F7026A5153Q41715897-727EA710-2E32-4733-B6A4-4192BAF4815AQ42033890-841CDE4C-F551-4AD2-973C-E9311408E96CQ42245186-18DF8FB1-8080-4FC3-B521-2DDA6F8AB7EDQ47269501-7B8E15F3-A719-48EF-BE5A-ECA60D3F2A9FQ53696162-D925B1E6-C3BE-401B-AEBE-6E72F96C8D47Q54296736-E8F65233-C98E-49B9-BD79-438F55EB363C
P2860
Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Construction and characterizat ...... and immunogenicity in humans.
@ast
Construction and characterizat ...... and immunogenicity in humans.
@en
Construction and characterizat ...... and immunogenicity in humans.
@nl
type
label
Construction and characterizat ...... and immunogenicity in humans.
@ast
Construction and characterizat ...... and immunogenicity in humans.
@en
Construction and characterizat ...... and immunogenicity in humans.
@nl
prefLabel
Construction and characterizat ...... and immunogenicity in humans.
@ast
Construction and characterizat ...... and immunogenicity in humans.
@en
Construction and characterizat ...... and immunogenicity in humans.
@nl
P2093
P2860
P1476
Construction and characterizat ...... and immunogenicity in humans.
@en
P2093
Darsley MJ
Londoño-Arcila P
P2860
P304
P356
10.1128/IAI.69.8.4969-4979.2001
P407
P577
2001-08-01T00:00:00Z